Table 5 Differences in within-group and between-group differences in secondary outcome measures
|  | Foot orthoses (n = 12) | Flat insert (n = 11) |  | ||||
|---|---|---|---|---|---|---|---|
Baseline | 6 weeks | Mean change (6 weeks—baseline) | Baseline | 6 weeks | Mean change (6 weeks—baseline) | Foot orthoses—flat inserts adjusted mean difference (95% CI) 6 weeks^ | |
Maximum VAS on most aggravating activity (0 to 100 mm) | 51.6 (20.3) | 24.6 (26.4) | − 27.0 (22.5) | 73.2 (25.3) | 66.0 (36.9) | − 7.2 (26.0) | − 21.9 (− 46.0 to 2.1) |
Average VAS on most aggravating activity (0 to 100 mm) | 39.2 (20.0) | 14.5 (16.5) | − 24.7 (22.4) | 58.8 (25.8) | 38.6 (29.1) | − 20.1 (27.7) | − 15.8 (− 36.6 to 4.9) |
AKPS (0 to 100) | 62.0 (12.2) | 72.5 (17.2) | 10.5 (14.6) | 46.4 (10.9) | 49.1 (21.5) | 2.7 (17.9) | 9.1 (− 8.6 to 26.8) |
KOOS—pain (0 to 100) | 67.8 (10.8) | 79.4 (13.3) | 11.7 (13.8) | 54.2 (12.5) | 60.0 (20.9) | 5.8 (15.3) | 8.1 (− 6.9 to 23.1) |
KOOS—symptoms (0 to 100) | 64.6 (18.3) | 67.0 (16.6) | 2.4 (10.6) | 56.1 (15.1) | 56.4 (17.8) | 0.3 (14.8) | 4.4 (− 6.6 to 15.5) |
KOOS—ADL (0 to 100) | 80.7 (10.6) | 87.7 (14.2) | 7.0 (8.6) | 59.6 (19.8) | 56.1 (21.8) | − 3.5 (15.9) | 13.7 (0.2 to 27.2) |
KOOS—sport/recreation (0 to 100) | 37.1 (20.2) | 56.3 (30.4) | 19.2 (29.0) | 15.0 (11.6) | 20.0 (21.3) | 5.0 (23.9) | 25.7 (− 1.7 to 53.0) |
KOOS—QOL (0 to 100) | 50.5 (12.9) | 62.7 (14.4) | 12.2 (11.2) | 34.2 (16.1) | 37.7 (20.0) | 3.5 (13.8) | 11.3 (− 1.4 to 24.0) |